Meet the Team
Meet the Team
Our team draws on neurology experience and networks to optimize the development process and create the most relevant outcomes for our clients
Our team draws on neurology experience and networks to optimize the development process and create the most relevant outcomes for our clients
Head of Neurotrials & Medical Lead
Dr Louise-Laure Mariani (MD, PhD) is a Neurologist and Neuroscientist with a specialization in neuropharmacology.
She has an expertise in neurological disorders, such as Parkinson’s disease, cerebellar ataxia, other movement disorders and neurogenetics.
Associate Professor of neuropharmacology at the Pitié-Salpêtrière Hospital (Paris, Sorbonne University), and investigator in many international clinical trials.
She works in close collaboration with the various french reference centers for neurological diseases.
Clinical Operations Manager
Pierre Georges François (MSc) has been working in the field of clinical development for more than 15 years within the Pharmaceutical industry and CROs.
During more than 10 years, he managed clinical trials in various therapeutic areas, from Phase I first-in-Man clinical trials to pivotal phase III trials.
Head of Neurotrials & Medical Lead
Dr Louise-Laure Mariani (MD, PhD) is a Neurologist and Neuroscientist with a specialization in neuropharmacology.
She has an expertise in neurological disorders, such as Parkinson’s disease, cerebellar ataxia, other movement disorders and neurogenetics.
Associate Professor of neuropharmacology at the Pitié-Salpêtrière Hospital (Paris, Sorbonne University), and investigator in many international clinical trials.
She works in close collaboration with the various french reference centers for neurological diseases.
Clinical Operations Manager
Pierre Georges François (MSc) has been working in the field of clinical development for more than 15 years within the Pharmaceutical industry and CROs.
During more than 10 years, he managed clinical trials in various therapeutic areas, from Phase I first-in-Man clinical trials to pivotal phase III trials.
Clinical Project Manager
Jennifer Thibault holds a Master in Ethology from Paris XIII University and a Master’s Degree in Cognitive and Behavioural Neuroscience, from Sorbonne University.
After working as a research assistant in fundamental research in Neuroscience (Montreal, Canada), she worked in Paris in international CROs as a monitor Clinical Research Associate.
She then specialized in start-up unit, first as a specialized Clinical Research Associate in sites’ selection and then as a start-up Regulatory Specialist, with the Project team leader cap.
Clinical Research Associate
Maud Jourdan (MSc) worked several years as an Engineer at the French Institute of Health and Medical Research (INSERM) in fondamental stem cell research.
She specialized in clinical research. Maud worked as a consultant for the leading academic promoter of oncology clinical trials in Europe.
She joined Neurotrials as a Clinical Research Associate to work on early phase clinical trials in brain diseases.
Clinical Project Manager
Jennifer Thibault holds a Master in Ethology from Paris XIII University and a Master’s Degree in Cognitive and Behavioural Neuroscience, from Sorbonne University.
After working as a research assistant in fundamental research in Neuroscience (Montreal, Canada), she worked in Paris in international CROs as a monitor Clinical Research Associate.
She then specialized in start-up unit, first as a specialized Clinical Research Associate in sites’ selection and then as a start-up Regulatory Specialist, with the Project team leader cap.
Clinical Research Associate
Maud Jourdan (MSc) worked several years as an Engineer at the French Institute of Health and Medical Research (INSERM) in fondamental stem cell research.
She specialized in clinical research. Maud worked as a consultant for the leading academic promoter of oncology clinical trials in Europe.
She joined Neurotrials as a Clinical Research Associate to work on early phase clinical trials in brain diseases.
Regulatory Affairs Officer
Jennifer Idusogie is a pharmacist graduated from the University of Clermont-Auvergne. She completed her curriculum with a Master’s degree in Regulatory Affairs.
She has supported regulatory affairs activities in the pharmaceutical industry on drug development and post-marketing projects.
Quality Assurance Manager
Magali Régnier has a PhD in cellular and molecular biology followed by a post-doctorate in cellular biology and microbiology. cellular biology and microbiology.
She started as a hospital-based CRA in Paris before becoming co-manager of a Clinical Research and Innovation Department. After a specialisation as a clinical project manager in implantable medical devices where she was also an internal auditor and DPO, she is currently responsible for quality assurance within Neurotrials and contributes to its expertise in reglementary affairs concerning the medical devices.
Regulatory Affairs Officer
Jennifer Idusogie is a pharmacist graduated from the University of Clermont-Auvergne. She completed her curriculum with a Master’s degree in Regulatory Affairs.
She has supported regulatory affairs activities in the pharmaceutical industry on drug development and post-marketing projects.
Quality Assurance Manager
Magali Régnier has a PhD in cellular and molecular biology followed by a post-doctorate in cellular biology and microbiology. cellular biology and microbiology.
She started as a hospital-based CRA in Paris before becoming co-manager of a Clinical Research and Innovation Department. After a specialisation as a clinical project manager in implantable medical devices where she was also an internal auditor and DPO, she is currently responsible for quality assurance within Neurotrials and contributes to its expertise in reglementary affairs concerning the medical devices.
Medical Writer
Julien Serusclat is an industrial pharmacist.
He graduated from Paris-Saclay University with a specialization in regulatory affairs.
He has been supporting the clinical development of a wide range of investigational drugs, from the small chemical compound to the neural stem cell, within small and big pharma abroad (Switzerland and UK) before returning to France to join the Paris Brain Institute.
Julien has an extensive experience in writing scientific, clinical and regulatory documents.
We optimize your product’s value to enable a successful drug / medical device development process.
Medical Writer
Julien Serusclat is an industrial pharmacist.
He graduated from Paris-Saclay University with a specialization in regulatory affairs.
He has been supporting the clinical development of a wide range of investigational drugs, from the small chemical compound to the neural stem cell, within small and big pharma abroad (Switzerland and UK) before returning to France to join the Paris Brain Institute.
Julien has an extensive experience in writing scientific, clinical and regulatory documents.